SMTL ID : 3n2n.1

The Crystal Structure of Tumor Endothelial Marker 8 (TEM8) extracellular domain

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

homo-hexamer

Ligands

18 x ACT: ACETATE ION(Non-functional Binders)

ACT.1: 8 residues within 4Å: Chain A: S.17, G.18, S.19, G.81, D.82, T.83 Ligands: MG.2, ACT.3 Ligand excluded by PLIP ACT.3: 2 residues within 4Å: Chain A: H.119 Ligands: ACT.1 Ligand excluded by PLIP ACT.4: 3 residues within 4Å: Chain A: K.37, F.38, H.178 Ligand excluded by PLIP ACT.5: 4 residues within 4Å: Chain A: K.16, V.49, L.57, V.77 Ligand excluded by PLIP ACT.7: 7 residues within 4Å: Chain B: S.17, G.18, S.19, G.81, D.82, T.83 Ligands: MG.6 Ligand excluded by PLIP ACT.8: 4 residues within 4Å: Chain B: K.16, V.49, L.57, V.77 Ligand excluded by PLIP ACT.9: 3 residues within 4Å: Chain B: K.37, F.38, H.178 Ligand excluded by PLIP ACT.11: 8 residues within 4Å: Chain C: S.17, G.18, S.19, G.81, D.82, T.83 Ligands: MG.10, ACT.13 Ligand excluded by PLIP ACT.12: 5 residues within 4Å: Chain C: K.16, V.49, L.57, E.73, V.77 Ligand excluded by PLIP ACT.13: 2 residues within 4Å: Chain C: H.119 Ligands: ACT.11 Ligand excluded by PLIP ACT.14: 4 residues within 4Å: Chain C: K.37, F.38, H.178, L.181 Ligand excluded by PLIP ACT.16: 7 residues within 4Å: Chain D: S.17, G.18, S.19, G.81, D.82, T.83 Ligands: MG.15 Ligand excluded by PLIP ACT.17: 3 residues within 4Å: Chain D: K.37, F.38, H.178 Ligand excluded by PLIP ACT.19: 7 residues within 4Å: Chain E: S.17, G.18, S.19, G.81, D.82, T.83 Ligands: MG.18 Ligand excluded by PLIP ACT.20: 4 residues within 4Å: Chain E: K.16, V.49, L.57, V.77 Ligand excluded by PLIP ACT.21: 3 residues within 4Å: Chain E: K.37, F.38, H.178 Ligand excluded by PLIP ACT.23: 7 residues within 4Å: Chain F: S.17, G.18, S.19, G.81, D.82, T.83 Ligands: MG.22 Ligand excluded by PLIP ACT.24: 3 residues within 4Å: Chain F: K.37, F.38, H.178 Ligand excluded by PLIP

6 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 4 residues within 4Å: Chain A: S.17, S.19, T.83 Ligands: ACT.1 5 PLIP interactions: 3 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:S.17, A:S.19, A:T.83, H2O.1, H2O.4 MG.6: 4 residues within 4Å: Chain B: S.17, S.19, T.83 Ligands: ACT.7 5 PLIP interactions: 3 interactions with chain B, 2 Ligand-Water interactions Metal complexes: B:S.17, B:S.19, B:T.83, H2O.10, H2O.14 MG.10: 4 residues within 4Å: Chain C: S.17, S.19, T.83 Ligands: ACT.11 5 PLIP interactions: 3 interactions with chain C, 2 Ligand-Water interactions Metal complexes: C:S.17, C:S.19, C:T.83, H2O.19, H2O.23 MG.15: 4 residues within 4Å: Chain D: S.17, S.19, T.83 Ligands: ACT.16 5 PLIP interactions: 3 interactions with chain D, 2 Ligand-Water interactions Metal complexes: D:S.17, D:S.19, D:T.83, H2O.31, H2O.32 MG.18: 4 residues within 4Å: Chain E: S.17, S.19, T.83 Ligands: ACT.19 5 PLIP interactions: 3 interactions with chain E, 2 Ligand-Water interactions Metal complexes: E:S.17, E:S.19, E:T.83, H2O.36, H2O.36 MG.22: 4 residues within 4Å: Chain F: S.17, S.19, T.83 Ligands: ACT.23 5 PLIP interactions: 3 interactions with chain F, 2 Ligand-Water interactions Metal complexes: F:S.17, F:S.19, F:T.83, H2O.45, H2O.48

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fu, S. et al., The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin. Plos One (2010)

Release Date

2011-01-05

Peptides

Anthrax toxin receptor 1: ABCDEF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
F

B
A

C
B

D
C

E
D

F
E

Anthrax toxin receptor 1

Related Entries With Identical Sequence